GSK (MEX:GSK N) Moat Score : 7/10 (As of Jul. 05, 2025)

View and export this data going back to 2003. Start your Free Trial

What is GSK Moat Score?

GSK has the Moat Score of 7, which implies that the company might have Wide Moat - Entry-level wide moat, clearly possessing durable advantages.

GSK has Wide Moat: GSK PLC possesses a wide moat with strong brand strength, valuable patents, and significant R&D capabilities. Its durable cost advantages and regulatory barriers in pharmaceuticals provide robust competitive advantages.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes GSK might have Wide Moat - Entry-level wide moat, clearly possessing durable advantages.

Competitive Comparison of GSK's Moat Score

For the Drug Manufacturers - General subindustry, GSK's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GSK's Moat Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, GSK's Moat Score distribution charts can be found below:

* The bar in red indicates where GSK's Moat Score falls into.

Save Embed

;

Save Embed

;

GSK (MEX:GSK N) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score	Moat Level
10	Wide Moat - Exceptionally dominant and durable wide moat
8 - 9	Wide Moat - Clear and robust wide moat
7	Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6	Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5	Narrow Moat - Solid narrow moat
4	Narrow Moat - Discernible but modest moat
1 - 3	No Moat - Very weak/transient advantages
0	No Moat - No discernible moat

GSK Moat Score Related Terms

Thank you for viewing the detailed overview of GSK's Moat Score provided by GuruFocus.com. Please click on the following links to see related term pages.

GSK Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GSK PLC (MEX:GSK N) » Definitions » Moat Score

Comparable Companies

Traded in Other Exchanges

GLAXF:USA GSK:USA GSK1:Mexico GSKl:UK GSK:UK GS70:Germany GS71:Germany GS71:Germany GS70:Germany GS71:Germany GS70:Germany GS71:Germany G1SK34:Brazil GSK:Argentina

Address

79 New Oxford Street, London, GBR, WC1A 1DG

Website

https://www.gsk.com

In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.

GSK Headlines

No Headlines